DRUG · Unmapped registry intervention
Compound 21
Find medicine records ·
Find other trials using this name
Clinical trial
Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia
NCT06157580
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Angiotensin II
Normalized identity: angiotensin IIView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedBalance of Angiotensin II Receptors in Vessel Function After Preeclampsia
Design: INTERVENTIONAL · Status: COMPLETED · Phase: EARLY_PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Preeclampsiaverified · MONDO: preeclampsia
Interventions
Compound 21DRUG
Angiotensin IIDRUG · verified · RxNorm: angiotensin II
Sponsors & collaborators
Anna Stanhewicz, PhDlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06157580 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.